News Updates

More Articles Back to Article

UK grants GMP certification to cannabis API facility

The UK Medicines and Healthcare products Regulatory Agency certified Celadon's good manufacturing practice facility in the country's Midlands region to manufacture a cannabis-derived active pharmaceutical ingredient. "With the receipt of GMP registration, Celadon has joined a very select group of cannabis-focused pharmaceutical companies globally," said company CEO James Short. PharmaTimes magazine (UK) (1/16)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!